---
figid: PMC4112511__nihms584563f1
figtitle: 'Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4112511
filename: nihms584563f1.jpg
figlink: /pmc/articles/PMC4112511/figure/F1/
number: F1
caption: Synthesis pathways are in blue. Proteolytic pathways are in red. The dotted
  lines represent pathways that are not well characterized. Anabolic signals activate
  the PI-3 Kinase/Akt/mTOR pathway resulting in protein synthesis. Inactivity and
  inflammatory cytokines result in activation of NF-κB and Fox-O mediated induction
  of genes resulting in muscle atrophy. Fox-O activates transcription of ubiquitin
  proteasome ligases resulting in protein degradation. PI3-Kinase/AKT phosphorylates
  Fox-O preventing its nuclear translocation and inhibiting its activity. Fox-O when
  active can inhibit the mTOR pathway. Also, mTOR pathway activation inhibits protein
  degradation by lysosomal caspases. Myostatin causes muscle atrophy, via activating
  Fox-O and inhibiting PI3-K.IGF-1= insulin like growth factor 1, BCAA= branched chain
  amino acids, PI3-K= phosphoinositol 3 kinase, mTOR= mammalian target of rapamycin,
  NF-κB= nuclear transcription factor kappa B. Fox-O= transcription factor forkhead
  O
papertitle: 'Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic
  Options.'
reftext: Sumbul Ali, et al. Gerontology. ;60(4):294-305.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8377895
figid_alias: PMC4112511__F1
figtype: Figure
redirect_from: /figures/PMC4112511__F1
ndex: ba2bcec0-df1d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4112511__nihms584563f1.html
  '@type': Dataset
  description: Synthesis pathways are in blue. Proteolytic pathways are in red. The
    dotted lines represent pathways that are not well characterized. Anabolic signals
    activate the PI-3 Kinase/Akt/mTOR pathway resulting in protein synthesis. Inactivity
    and inflammatory cytokines result in activation of NF-κB and Fox-O mediated induction
    of genes resulting in muscle atrophy. Fox-O activates transcription of ubiquitin
    proteasome ligases resulting in protein degradation. PI3-Kinase/AKT phosphorylates
    Fox-O preventing its nuclear translocation and inhibiting its activity. Fox-O
    when active can inhibit the mTOR pathway. Also, mTOR pathway activation inhibits
    protein degradation by lysosomal caspases. Myostatin causes muscle atrophy, via
    activating Fox-O and inhibiting PI3-K.IGF-1= insulin like growth factor 1, BCAA=
    branched chain amino acids, PI3-K= phosphoinositol 3 kinase, mTOR= mammalian target
    of rapamycin, NF-κB= nuclear transcription factor kappa B. Fox-O= transcription
    factor forkhead O
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - foxo
  - Dif
  - dl
  - Rel
  - CG11700
  - Mtor
  - Tor
  - IGF1
  - ARID4B
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - NFKB1
  - MTOR
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - FBN1
  - Testosterone
  - Cancer
---
